Cappello Joseph

Chief Technical Officer at GNLX

Sold, on record
$154k
Dollars the filings state
Form 4 sales
8
Latest Aug 31, 2026
Form 144 notices
1
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • GNLXGENELUX CorpChief Technical Officer

Sales by reason

0
Routine
0
Plan not stated
5
No plan
3
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Timeline

  1. 1 Form 4 sale GNLXUnusual
    Aug 18, 2023 2023

    Sold 3,265 shares at $23.73 ($77k)

    Cappello Joseph, VP, Pharmaceutical Development

    No 10b5-1 planSold 36.3% of holdings ($214k position)5,735 shares leftFirst sale on recordFollows a Form 144Filing

  2. 2 Form 4 sale GNLXUnusual
    Dec 16, 2024 +486 days

    Sold 6,300 shares at $2.34 ($15k)

    Cappello Joseph, VP, Pharmaceutical Development

    No 10b5-1 planSold 30.1% of holdings ($49k position)14,653 shares leftFiling

  3. 3 Form 4 sale GNLXNo plan
    May 12, 2025 +147 days

    Sold 4,737 shares at $2.92 ($14k)

    Cappello Joseph, VP, Pharmaceutical Development

    No 10b5-1 planSold 8.3% of holdings ($166k position)52,266 shares leftFiling

  4. 4 Form 4 sale GNLXNo plan
    Nov 17, 2025 +189 days

    Sold 3,706 shares at $3.88 ($14k)

    Cappello Joseph, Chief Technical Officer

    No 10b5-1 planSold 2.3% of holdings ($619k position)156,060 shares leftFiling

  5. 5 Form 4 sale GNLXNo plan
    Mar 24, 2026 +127 days

    Sold 906 shares at $2.42 ($2k)

    Cappello Joseph, Chief Technical Officer

    No 10b5-1 planSold 0.6% of holdings ($378k position)155,154 shares left0.2x usual sizeFiling

  6. 6 Form 4 sale GNLXNo plan
    May 11, 2026 +48 days

    Sold 605 shares at $2.97 ($2k)

    Cappello Joseph, Chief Technical Officer

    No 10b5-1 planSold 0.4% of holdings ($461k position)154,549 shares left0.1x usual sizeFiling

  7. 7 Form 4 sale GNLXNo plan
    Aug 4, 2026 +85 days

    Sold 653 shares at $2.95 ($2k)

    Cappello Joseph, Chief Technical Officer

    No 10b5-1 planSold 0.2% of holdings ($972k position)328,737 shares left0.2x usual sizeFiling

  8. 8 Form 4 sale GNLXUnusual
    Aug 31, 2026 +27 days

    Sold 10,257 shares at $2.74 ($28k)

    Cappello Joseph, Chief Technical Officer

    No 10b5-1 planSold 3.1% of holdings ($901k position)318,480 shares left4.4x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (9)

Form 144 notices and Form 4 sales by Cappello Joseph
Source
Aug 31, 2026Sep 2, 2026GNLXChief Technical OfficerForm 4 sale10,257$28k3.1%UnusualSEC
Aug 4, 2026Aug 4, 2026GNLXChief Technical OfficerForm 4 sale653$2k0.2%No planSEC
May 11, 2026May 12, 2026GNLXChief Technical OfficerForm 4 sale605$2k0.4%No planSEC
Mar 24, 2026Mar 26, 2026GNLXChief Technical OfficerForm 4 sale906$2k0.6%No planSEC
Nov 17, 2025Dec 11, 2025GNLXChief Technical OfficerForm 4 sale3,706$14k2.3%No planSEC
May 12, 2025May 13, 2025GNLXVP, Pharmaceutical DevelopmentForm 4 sale4,737$14k8.3%No planSEC
Dec 16, 2024Dec 18, 2024GNLXVP, Pharmaceutical DevelopmentForm 4 sale6,300$15k30.1%UnusualSEC
Aug 18, 2023Aug 22, 2023GNLXVP, Pharmaceutical DevelopmentForm 4 sale3,265$77k36.3%UnusualSEC
Aug 18, 2023Aug 18, 2023GNLXOfficerForm 144 notice3,274$78kNoticeSEC